Abstract
Exposures to persistent organic pollutants (POPs) have been associated with steatotic liver disease (SLD), but how these chemicals impact women’s liver health is underexplored. Our goal was to determine the sex-specific impact of POPs on SLD and identify underlying sex-specific mechanisms. Male and female C57BL/6 mice were fed either a low-fat control diet (CD) or western diet (WD) and exposed to the vehicle control or a POP mixture of chlordane (20 mg/kg) and PCB 126 (20μg/kg) over 12 weeks. Another group of intact or ovariectomized (OVX) female mice were exposed to the same POP mixture/vehicle control for 2 weeks. Compared to their diet- and sex-matched controls, WD-fed females exposed to the POP mixture exhibited steatosis, confirmed by H&E staining and quantification of hepatic triglycerides/cholesterol, and decreased physical activity (assessed using metabolic chambers). These observations were absent in males. Mechanistically, POPs activated hepatic xenobiotic receptors, namely the arylhydrocarbon receptor and constitutive androstane receptor (CAR), measured by Cyp1a1/Cyp1a2 and Cyp2b10 induction respectively. However, more robust CAR activation was observed in CD-fed females. This group also showed decreased liver gene expression of estrogen sulfotransferase (Sult1e1), a key enzyme in estrogen metabolism. Further, POPs induced hepatomegaly and resistance to glucose clearance only in intact, but not OVX females, suggesting that altered estrogen signaling by POPs played a mechanistical role in driving hepatic POP-mediated toxicity in females. Female mice exposed to the POP mixture were more susceptible to toxicant-associated SLD. Our findings emphasized the significance of examining biological sex in assessing environmental liver disease risk.
Keywords: persistent organic pollutants, toxicant-associated, steatotic liver disease, xenobiotic receptors, sex differences
Graphical Abstract

INTRODUCTION
Exposures to occupational chemicals and environmental pollutants have been associated with elevated liver enzymes in human epidemiological studies and metabolic dysfunction-associated steatotic liver disease (MASLD) in experimental models (Beier et al., 2025). Terminologies were defined for these chemical-induced liver pathologies, namely, toxicant-associated steatotic liver disease (TASLD) and toxicant-associated steatohepatitis (TASH) (Cave et al., 2010). Similar to MASLD, TASLD/TASH is a continuum of pathological disorders in the liver initially characterized by lipid accumulation in the hepatocytes. Steatosis is often accompanied by neutrophil infiltration and Kupffer cell activation leading to steatohepatitis, and can progress to fibrosis, cirrhosis, and hepatocellular carcinoma. Associations between occupational chemical exposures and liver disease outcomes were primarily reported in chemical/agricultural workers who were chiefly men and liver toxicity studies performed mostly in male animal models (Wahlang, 2023). Critical knowledge gaps exist in terms of how these chemicals impact women’s health, specifically in the context of biological sex and its role in dictating liver responses to such external insults.
Sexual dimorphism of the liver has been well-documented and various species-specific mechanisms elucidated (Holloway et al., 2008; Rodriguez-Montes et al., 2023; Waxman and Holloway, 2009). However, how these sex-specific differences of the liver impact responses to toxicant exposures are still understudied (Wahlang, 2023). Potential pathways driving sex-specific metabolic dysfunction and TASLD have been identified and include exposure routes and absorption, and hepatic receptor expression and crosstalk. These events result in sex-dependent differences in chemical toxicokinetics, and in immune and inflammatory responsiveness. Thus, biological sex can modulate “gene-environment” interactions that define how toxicants impact and modify physiological processes (Wahlang, 2023). Further, biological processes throughout the lifespan differ between males and females, and are confounded by factors such as pregnancy and menopause (Wahlang, 2018). Thus, consideration of biological sex is imperative in elucidating liver xenobiotic responses in disease etiology.
Persistent organic pollutants (POPs) are a well-documented category of chemicals in liver disease and considered “forever chemicals” due to their environmental persistence. Although legacy POPs including polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCPs) have been banned for over three decades, they remain detected in human blood and wildlife (Wu et al., 2024). Due to their resistance to metabolism and degradation, POPs can also bioaccumulate in living organisms. with the predominant route of POP exposures today being ingestion of POP-contaminated foods (Wu et al., 2024; Yu et al., 2024). Thus, POPs are food contaminants that can bio-magnify through the food chain (Batt et al., 2017) and pose a legitimate concern to public health in the rise of chronic diseases today.
Mechanistic contributions for individual categories of POPs have been elucidated in male models of liver disease (Wahlang et al., 2019a). POPs, including “dioxin-like” and “non-dioxin-like” PCBs and OCPs, act as endocrine and metabolism disrupting chemicals (EDCs, MDCs) by interacting with hepatic xenobiotic and sex hormone receptors (Cano et al., 2021), inhibiting insulin production and subsequent glucose uptake (Lee et al., 2018; Mimoto et al., 2017; Shi et al., 2019), and altering secretory levels of adipokines (Shannon et al., 2019; Wahlang et al., 2013). EDCs and MDCs also have the capacity to stimulate metabolic perturbations which can result in obesity, diabetes and MASLD. The vast majority of POPs induce liver and metabolic toxicity as EDCs/MDCs (Heindel et al., 2017; Wahlang et al., 2019a). Nonetheless, studies determining the contributions of POPs to TASLD/TASH focused largely on individual chemicals or congeners. Therefore, how mixtures of these chemicals drive liver disease pathology are still poorly understood.
Given the significance of sex differences in liver disease, and the urgent need to address pressing health outcomes associated with chemical exposures, the goal of the current study was to determine the sex-specific impact of an environmentally-relevant mixture of POPs on MASLD. Using a rodent exposure model, this study utilized a mixture of POPs, namely PCB 126 and technical chlordane, a former commercial pesticide, since the combination of OCPs and PCBs is often detected together in food and contaminated water (Batt et al., 2017). With emerging evidence that western diet interacts with environmental exposures to elevate risks for chronic diseases, we examined these POP-mediated liver outcomes in the context of a hypercaloric diet.
METHODS
Animal Model
The animal studies were approved by the University of Louisville Institutional Animal Care and Use Committee (IACUC) and performed in accordance with the National Research Council Guide for the Care and Use of Laboratory Animals and the ARRIVE guidelines. Male and female C57BL/6 mice (6–8-week-old) were obtained from The Jackson Laboratory (Bar Harbor, ME) and housed in a temperature- and light- controlled room (12 h light; 12 h dark) with food and water ad libitum. Four mice were housed per cage. All mice were fed a low-fat, synthetic diet (TD.06416, Inotiv, Lafayette, IN, USA) designated as control diet (CD) or a high-fat, high-carbohydrate synthetic diet (TD.88137) designated as Western Diet (WD). Diet composition is provided in Supplemental Table S1. Mice were randomly divided into eight groups (n=12 per group) based on sex, diet and exposure utilizing a 2×2×2 design. Vehicle control (corn oil) or the POP mixture of chlordane (20 mg/kg) + PCB126 (20μg/kg) were administered via oral gavage over the 12-week study period as shown in Figure 1A. Body weight (BW) and food consumption were recorded weekly. Estrus cycle was monitored in female mice by vaginal cytology method (Pantier et al., 2019). During week 10–12, a glucose tolerance test was performed as described (Bolatimi et al., 2024), and mice (n=4) were randomly selected for metabolic chamber studies (TSE PhenoMaster Cage Systems, Bad Homburg, Germany). In another animal group, female C57BL/6 mice (6–8-week-old) on CD feeding underwent surgical ovariectomy (OVX) or a sham operation. Vaginal cytology confirmed that OVX mice did not undergo estrus cycling. Post recovery, mice were divided into four groups (n=6) and administered the same POP mixture or vehicle control via a one-time oral gavage followed by study termination 2 weeks post gavage (Figure 1B). Prior to euthanasia, body composition analysis was performed using the EchoMRI-500 Body Composition Analyzer (Echo Medical Systems, Houston, TX, USA). At study termination, mice were euthanized using ketamine/xylazine (100/20 mg/kg, i.p.). Plasma and organ/tissue samples including liver were collected for downstream analysis.
Figure 1. Experimental timeline and effects on body composition.

A schematic of the exposure design and timeline for the A) sub-chronic 12-week study with and without western diet feeding (n=12), and the B) 2-week study in an ovariectomized (OVX) model (n=6). C) Body weight (BW) was measured in the 12-week study and the percentage increase in BW relative to the initial body weight taken at the beginning of the study (considered as 100%) was calculated. D, E) Body fat and lean tissue mass were determined using the Echo-MRI and calculated relative to BW. F) Mice from each group (n=4) in the 12-week study were placed in TSE metabolic chambers and physical activity (ambulatory movement) measured in the dark cycle. Organs, including whole livers and spleens were harvested at study euthanasia and the G) liver to body weight ratio (%) and H) spleen to body weight ratio (%) calculated. Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold. CD-control diet, WD-western diet.
Dose Rationale
The chemical doses in the pollutant mixture were designed based on human serum levels from the CDC’S National Report NHANES database (1999–2018), relevant to the American population, and extrapolating those levels to circulating levels in rodents based on previous studies’ measurements including the National Toxicology Program (NTP). The cumulative doses used in this study are Chlordane at 20mg/kg and PCB 126 at 20 μg/kg. Chlordane and PCB 126 were administered once every two weeks (bimonthly) as a mixture at individual doses of 4 mg/kg and 4 μg/kg respectively from Week 1 to Week 10 of the study or a one-time dose of Chlordane (20mg/kg) + PCB 126 (20 μg/kg). According to the National Report, the highest serum levels (lipid-adjusted) of oxychlordane, the chlordane metabolite, in NHANES participants (pooled samples) was 52.9 ng/g (2018). In previous NTP studies, liver levels of POPs were usually 10 times higher than that in serum (National Toxicology, 2006a). When applying this to chlordane metabolites, the estimated liver levels of oxychlordane will be ~500 ng/g in NHANES participants. Daily administration of technical-grade chlordane at 1.43 mg/kg for 21 days resulted in oxychlordane liver metabolite levels ranging from 150 ng/g in low fat diet-fed mice to 250 ng/g in high fat diet-fed mice (Wang et al., 2017). At the proposed dose of 20 mg/kg, hepatic oxychlordane levels are expected to be ~160 ng/g which correlates with average human bioaccumulated levels. With regards to PCB 126, exposures by total PCB mass to dioxin-like PCBs including PCB 126 is >0.1% of the total PCB exposures in NHANES participants. Thus, PCB 126 was designed to mimic this low-dose pattern seen with human exposures.
Histology and other Methods
The methods for histological analysis of liver sections, plasma analyte measurements, quantification of hepatic lipids and glutathione levels (GSH), RT-PCR and western blot analysis, along with the list of primers and antibody information are provided in Supplemental Methods. Detailed description of the proteomics methodology used is also provided in Supplemental Methods.
Statistical Analysis
Statistical analyses of the proteomic data were performed using R software as described in Supplemental Methods. Computational analyses on significantly altered proteins for each comparison group were performed using MetaCore (Clarivate Analytics). All graphs were plotted using GraphPad Prism 10.5.0 (GraphPad Software Inc., La Jolla, CA, USA) unless specified otherwise. Two- or Three-way ANOVA with two-way interactions were first performed to evaluate the effects of sex, diet and exposure, with p-values provided in the relevant figures/tables. Post-hoc t-tests were then conducted to examine contrasts of interests within each sex, and family-wise error rate for multiple comparisons controlled using Bonferroni correction (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
RESULTS
Changes in body composition
In general, males had higher BW vs. females and WD feeding increased BW in both sexes (Figure 1C). This effect was mirrored by body fat composition and white adipose tissue weights (Figure 1D). No differences in lean mass were observed in CD-fed mice, while WD feeding decreased lean mass composition in both sexes (Figure 1E). Metabolic phenotyping showed no major POP exposure effects, with the exception of physical activity where an interaction effect (Sex*Diet*Exposure) was observed for ambulatory movement with WD-fed, POP-exposed females showing the lowest physical activity than any of their exposed counterparts (Figure 1F). Liver and spleen weights were also measured at euthanasia. Sex differences were observed only in the WD groups where WD-fed males exhibited higher liver to BW ratios than WD-fed females (Figure 1G). WD feeding increased liver weights only in males but not females (Sex*Diet interaction). Notably, POP exposure increased liver to BW ratios with CD feeding, irrespective of sex. Females generally had higher spleen to BW ratios than males (Figure 1H). However, WD feeding decreased spleen weights in males but not females. Overall, while both biological sex and diet influenced body composition, the POP mixture only increased liver weights in CD-fed males and females.
POP exposure caused sex-specific steatosis with western diet feeding
Livers from CD-fed females generally had higher frequency of lipid droplets than males (Figure 2A&B), as previously reported for this mouse strain (Bolatimi et al., 2024). This was corroborated by higher hepatic triglyceride levels in CD-fed females vs. males (Figure 2C). As expected, WD feeding resulted in both micro- and macro-vesicular steatosis in both sexes (Figure 2A&B). However, sex differences were observed in the degree and pattern of steatosis. WD-fed males showing more lipid droplet coverage per microscopic area vs. females (Figure 2A). This was also confirmed by higher hepatic triglyceride levels in WD-fed males vs. WD-fed females indicating a Diet*Sex interaction (Figure 2C). However, WD-fed females showed higher hepatic cholesterol levels than their male counterparts (Figure 2D). Importantly, a Diet*Exposure effect was observed wherein WD-fed exposed females exhibited increased hepatic triglycerides and cholesterol compared to their sex- and diet-matched controls. No POP exposure-specific effects were observed for plasma triglycerides (Figure 2E). However, a Diet*Sex interaction was observed wherein WD-fed males showed lower plasma triglyceride levels than CD-fed males, but this effect was absent in females (Figure 2E). Females generally displayed lower plasma cholesterol levels than males irrespective of diet (Figure 2F), and, as anticipated, WD feeding increased plasma cholesterol in both sexes. Intriguingly, exposure to the POP mixture resulted in decreased plasma cholesterol levels only in males (Sex*Exposure interaction) and this cholesterol-lowering effect by POPs was more pronounced with WD feeding (Sex*Diet*Exposure interaction). POP-exposed, WD-fed mice also exhibited lower circulating high density lipoproteins (HDL) while no exposure effect was observed for other lipoproteins measured (Supplemental Table S2). Collectively, these data demonstrated that the POP exposure interacted with diet to worsen steatosis in females, as confirmed by hepatic lipid quantification, while this phenomenon was not observed in males.
Figure 2. Assessment of steatosis and lipid levels.

Liver sections were stained with A) Hematoxylin & Eosin (H&E) and B) Oil Red O (10x) to determine presence and degree of steatosis. WD-fed males demonstrated diffused micro- and macro-vesicular steatosis (black arrows) while WD-fed females showed more zonal and macro-vesicular steatosis (blue arrows). CD-fed females also showed presence of lipid droplets (blue arrows). Hepatic lipids were extracted and hepatic C) triglycerides and D) cholesterol levels were measured using colorimetric assays. Circulating lipids including E) plasma triglycerides and F) plasma cholesterol was measured using the Piccolo Xpress Chemistry Analyzer. Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold. CD-control diet, WD-western diet, CV-central vein, PV-portal vein.
Impact on liver inflammation and injury
Liver sections in the CD-fed females displayed CAE-positive areas, indicating presence of neutrophil infiltration (Figure 3A). Likewise, neutrophil infiltrates were also observed with WD feeding in both sexes, although sections from females showed more CAE-positive areas, independent of POP exposure. To further quantify liver injury, circulating liver enzymes were measured (Supplemental Table S2). While CD-fed males displayed higher plasma ALT levels compared to their female counterparts, WD feeding increased plasma ALT and AST in both sexes. POP exposure had no impact on these liver enzymes.
Figure 3. Sex-specific diet and exposure effects on liver inflammation and function.

To determine presence of inflammation, A) liver sections were stained with Chloroacetate esterase and Hematoxylin (CAE) (10x and 40x) to detect neutrophil infiltration, and hepatic mRNA levels of B) tumor necrosis factor (Tnfa) and C) the gene encoding tissue plasminogen activator inhibitor 1 (Serpine1) measured using RT-PCR. To assess the effects of diet and POP exposure on liver function, hepatic mRNA levels of D) albumin (Alb) and E) hepatocyte nuclear factor 4 alpha (Hnf4a) were also determined using RT-PCR. Hepatic glutathione (GSH) and glutathione disulfide (GSSG) levels were measured using HPLC, and the F) hepatic GSH/GSSG ratio and G) redox potential (EhGSSG) calculated. Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold. CD-control diet, WD-western diet.
Hepatic expression of genes encoding pro-inflammatory/pro-fibrotic and liver function markers were also examined. Consistent with histologic observations, female mice exhibited higher mRNA levels of pro-inflammatory markers including Tnfa and Il6 (sex effect), but not Timp1 (Figure 3B, Supplemental Figure S1). WD feeding increased hepatic expression of these markers in both sexes. Likewise, WD feeding increased liver expression of Serpine1, the gene encoding the pro-fibrotic marker, PAI-1, and this was more pronounced in males (Diet*Sex interaction). Notably, WD-fed, POP-exposed females showed higher Seprine1 mRNA levels than their sex- and diet-matched controls (Figure 3C). With regards to liver function markers, female mice displayed higher liver Alb expression levels than males while WD feeding decreased Alb expression in both sexes (Figure 3D). POP exposure also decreased Alb expression in both sexes in the CD group. Similar to Alb, WD feeding decreased liver Hnf4a expression in both sexes (Figure 3E). POP exposure resulted in increased liver Hnf4a expression in CD-fed males, but decreased Hnf4a expression in CD-fed females, indicating a Diet*Sex*Exposure interaction. The gene encoding the female-biased liver transcription factor Foxa1 also showed decreased expression in CD-fed, POP-exposed females (Supplemental Figure S1). Antioxidant capacity in the form of liver glutathione (GSH) and glutathione disulfide (GSSG) levels was also quantified. Males showed higher liver GSH and GSSG levels than females as denoted by the “sex” effect (Supplemental Figure S1). However, sex differences were lost when the GSH/GSSG ratio (reduced to oxidized form) was calculated (Figure 3F). As expected, WD feeding led to higher GSH/GSSG ratios in both sexes. Subgroup analysis demonstrated that POP exposure resulted in decreased GSH to GSSG ratio in the WD-fed males but not females. A similar pattern was observed in the redox potential calculated (EhGSSG) with POP exposure causing an increase in redox potential in the WD-fed males only (Figure 3G), implicating presence of oxidative stress in livers of WD-fed males but not females. Comprehensively, these data demonstrated while WD feeding largely modulate liver inflammation, POP exposure either independently or through sex and diet interactions, impacted liver gene expression for pro-fibrotic and liver function markers.
Changes in energy metabolism
Glucose tolerance tests were performed near the end of the 12-week study period. Glucose levels over the time course of the test were plotted and stratified by sex, for ease of data interpretation (Figure 4A). Area under the curve (AUC) was calculated and both sex and diet differences were noted (Supplemental Figure S2). Females showed lower AUC in general, and WD feeding increased the AUC in males but not females. Distinctly, POP exposure increased the AUC only in WD-fed males (Diet*Exposure interaction), notably at the 30-minute time-point (Figure 4A). Hepatic expression of key glucose metabolism genes was measured. WD reduced hepatic Pck1, the gene encoding the rate-limiting enzyme in gluconeogenesis, independent of sex or POP exposure (Figure 4B). In contrast, hepatic expression of Gck, the gene encoding glucokinase, was decreased with POP exposure only in WD-fed females (Sex*Exposure), (Figure 4C).
Figure 4. Changes in energy metabolism endpoints.

A) Glucose tolerance testing was performed toward the end of the 12-week study period and blood glucose levels post glucose challenge were recorded over a 2-hour period. Glucose levels at each 30-minute timepoint were plotted for males and females, and subgroup comparisons at individual timepoints performed. **p<0.05 vs. M-CON-WD and M-EXPOSED-CD, *p<0.05 M-EXPOSED-CD. Hepatic mRNA levels of glucose metabolism genes, namely B) Phosphoenolpyruvate carboxykinase 1 (Pck1) and C) glucokinase (Gck); and lipid metabolism genes, namely D) stearoyl-Coenzyme A desaturase 1 (Scd1), E) fatty acid binding protein (Fabp1), F) patatin-like phospholipase domain containing 2 (Pnpla2) and G) apolipoprotein B (Apob) were measured using RT-PCR. Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold. CD-control diet, WD-western diet.
To examine molecular events driving diet- and POP exposure-induced alterations in hepatic lipid content (Figure 2), lipid metabolism genes were analyzed. No major interactions were observed in the hepatic expression of genes involved in de novo lipogenesis (Supplemental Figure S2) except for Scd1 expression (Figure 4D) which was decreased in WD-fed, POP-exposed males vs. their control counterparts (Sex*Diet*Exposure interaction). In terms of lipid uptake and binding, WD feeding upregulated Cd36 expression (Supplemental Figure S2) while a Sex*Exposure effect was observed for Fabp1 which was decreased only in CD-fed, POP-exposed males (Figure 4D). Surprisingly, this same groups exhibited higher liver expression of Pnpla2, a key gene involved in lipolysis while no changes were observed in Cpt1a, the gene encoding the rate-limiting enzyme in fatty acid oxidation. With regards to lipid transport, mRNA levels of Apob were decreased only in CD-fed, POP-exposed females, implicating compromised lipoprotein export in this group. Other metabolic markers including adipokines (resistin, leptin) were measured and only diet effects were observed (Supplemental Table S2). Taken together, these data suggest that males appeared more resistant to WD-induced changes in glucose metabolism with POP exposure, and transcriptional alterations induced by POPs (e.g. Hnfa, Apob) were more prominent in the CD group and modulated by sex.
POPs activate xenobiotic receptors and modulate sex hormone receptor expression and their targets
As xenobiotic, POPs interact with hepatic xenobiotic receptors that mediate POP-induced hepatotoxicity. Concordantly, exposures to the POP mixture activated key xenobiotic receptors, determined by liver target gene transcript abundance. The classic AHR target genes, Cyp1a1 and Cyp1a2, were upregulated in all POP-exposed groups irrespective of sex or diet (Figure 5A&B). However, WD feeding resulted in lower induction levels for these drug metabolizing enzymes compared to the CD groups, suggesting a Diet*Exposure interaction. Similarly, the POP mixture induced Cyp2b10 in both sexes and diet groups, indicating CAR activation (Figure 5C) and a Diet*Exposure interaction akin to Cyp1a1 and Cyp1a2 was also observed. Curiously, the POP mixture appeared to activate PXR only in males as seen by prominent Cyp3a11 induction in exposed male mice while exposed females, particularly, the WD-fed group showed no induction (Figure 5D). Additionally, expression levels of key transcription factors pertinent to the study were also examined. Female mice generally showed higher expression levels of Esr1 and Ar, the genes encoding estrogen receptor alpha (ERα) and androgen receptor (AR), respectively (Figure 5E&F). Strikingly, CD-fed, POP-exposed males showed increased hepatic Ar expression vs. their matched controls as denoted by subgroup comparisons. This correlated with increased circulating testosterone levels in this group (Supplemental Figure S3) and agrees with our previous reports on chlordane-mediated testosterone upregulation in male mice(Luo et al., 2023). Despite no changes in Esr1 expression, WD feeding increased transcript levels of the estrogen metabolizing enzyme, namely estrogen sulfotransferase (Sult1e1) (Figure 5G). CD-fed, POP-exposed females also displayed higher Sult1e1 expression vs. their sex-matched CD controls. However, only POP-exposed, WD-fed mice demonstrated prolonged duration in the estrus phase vs. their sex-matched WD controls (Supplemental Figure S3). Lastly, the gene encoding the epidermal growth factor receptor (Egfr), critical for hepatocyte function and regeneration, showed sex and diet-dependent expression. Importantly, POP exposure resulted in reduced Egfr transcript levels in females (Sex*Exposure effect) and evident in CD-fed females (Figure 5H). Together, these hepatic transcript expression data indicated that in addition to POP-xenobiotic receptor activation, POPs also target sex hormone nuclear receptor (Ar) and metabolizing enzyme (Sult1e1), both of which are integral to sex hormone regulation. Significantly, WD masked several of the POP-mediated alterations.
Figure 5. Effects on liver xenobiotic receptor activation and sex hormone receptor expression.

Hepatic mRNA levels of target genes for the AHR namely A) Cyp1a1 and B) Cyp1a2, CAR target gene C) Cyp2b10 and PXR target gene D) Cyp3a11 were measured using RT-PCR to determine hepatic receptor activation by the POP mixture. Further, hepatic mRNA levels of sex hormone receptors, namely E) estrogen receptor alpha (Esr1) and F) androgen receptor (Ar), the estrogen-metabolizing enzyme G) estrogen sulfotransferase/sulfotransferase family 1E, member 1 (Sult1e1) and H) the epidermal growth factor receptor (Egfr) were also examined. Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold. CD-control diet, WD-western diet.
Alterations in the liver proteome
Discovery-based proteomics was performed on liver samples to identify changes in the liver proteome landscape with sex and POP exposure and stratified by diet. In both dietary groups, sex differences were the most pronounced effect (Supplementary Figure S4). POP exposure also resulted in altered protein expression in both sexes and dietary groups with top differentially expressed (DE) proteins including AHR and CAR targets (Supplementary Table S3). Key DE proteins identified from the proteomic analysis were validated by western blot analysis. Common DE proteins altered by POP exposure in both sexes in the CD and WD groups include increased CYP1A1 and CYP2B10 (Figure 6A & B). Other cytochrome P450s exhibited only sex differences including CY3A11, and the peroxisome-proliferator activated receptor (PPAR) alpha target, CYP4A10. Another top DE protein identified was the AHR target, namely flavin-containing monooxygenase 3 (FMO3), which displayed distinct sex-specific protein expression in both CD and WD groups (Figure 6A & B). Proteomic analysis revealed one protein exhibiting a Sex*Exposure interaction in the WD group, namely fatty acid synthase (FAS). Indeed, western blot analysis demonstrated that FAS protein expression was increased in WD-fed females exposed to POPs vs. their sex-matched controls but not in males (Figure 6B), thus confirming the proteomics findings.
Figure 6. Validation of proteomic findings.

Western blot analysis was performed to determine hepatic expression of key differentially expressed proteins identified with TMT-labelled proteomics for the 12-week study. Representative images are shown for the male and female mice with and without exposure in the A) control diet (CD) group, and in the B) western diet (WD) group along with densitometric ratios for each protein analyzed (n=10). Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold.
Computational analysis namely ‘Interaction by Protein Function’ (IPF) analysis demonstrated that transcription factors and xenobiotic and endobiotic receptors were the major proteins impacted, while enzymes and micro-RNAs were also identified (Figure 7A&B). Sex differences were apparent in protein activity (z-score) of major liver receptors despite the two diets. Specifically, with exposure, in the CD group, CAR and PXR showed higher z-scores in the female POP-exposed vs. unexposed group. In contrast, in the WD group, both CAR and PXR showed higher z-scores in male POP-exposed vs. unexposed group but not in females. POP exposure decreased z-scores, indicative of protein activity, for HNF4A in both sexes in the CD group and in male POP-exposed vs. unexposed group in the WD group. Notably, LXR alpha and VDR showed increased z-scores with POP exposure in both sexes in the WD group. Pathway enrichment analysis, namely ‘GO Process’, was performed for the male and female comparison groups to determine POP effects on biological processes (Figure 7C&D). As expected, the ‘epoxygenase P450 pathway’ was the top enriched pathway in both the male and female POP-exposed mice. Key processes that were enriched only in males in the CD group include metabolic processes related to gluconeogenesis, lipid storage and insulin receptor signaling, while only females showed enrichment for ‘regulation of estrogen secretion’. In the WD group, ‘cholesterol metabolic process’ was enriched only in male, POP-exposed mice, while female POP-exposed mice were enriched for processes related to estrogen and steroid hormone secretion, and unexpectedly vasoconstriction. Overall, the proteomic analysis confirmed several target gene induction observations, while identifying proteins and pathways modulated by interactions between sex and exposure including FAS.
Figure 7. Computational analysis of differentially expressed proteins.

An Interaction by Protein Function (IPF) analysis was performed on the differentially expressed proteins obtained for each comparison in the A) control diet (CD) group and B) western diet (WD) group using MetaCore. A heat map of selected objects obtained from the IPF analysis, along with their corresponding z-scores, was constructed. Increased z-score denotes increased activity. A heat map showing different processes that were altered by POP exposure according to the −log(p-value) in males and females in the C) CD group and D) WD group. The first experimental group mentioned in each comparison serves as the reference group. The processes were obtained by GO analysis enrichment of the different altered proteins using MetaCore.
Effects of POPs on an OVX model
To determine if the POP effects on liver and metabolic endpoints in females is driven, in part by estrogen signaling, a 2-week exposure study was performed in sham-operated and OVX mice. A glucose tolerance test performed at 10 days post POP administration demonstrated that OVX mice generally showed higher glucose intolerance (Figure 8A). POP exposure resulted in resistance to glucose uptake in sham mice, specifically at earlier timepoints of the test. OVX mice displayed higher BW and fat composition, but no POP exposure effects were observed (Supplemental Figure S5). Histological qualitative assessment of liver sections (H&E) revealed that POP-exposed sham mice showed presence of lipid droplets and inflammatory foci compared to their matched controls (Figure 8B), while OVX mice generally exhibited higher frequency of lipid droplets. POP-exposed sham mice but not OVX mice exhibited higher liver to BW ratios (Figure 8C). POP-exposed sham mice also exhibited decreased circulating plasma triglycerides (Figure 8D) accompanied by a non-significant trend for increased hepatic triglyceride content (Supplementary Figure S5). Similar to the 12-week observations, POP exposure induced AHR and CAR target genes, namely Cyp1a1 and Cyp2b10 in both sham and OVX mice (Figure 8E&F). However, hepatic Sult1e1 expression was not increased with the 2-week exposure in sham mice (Figure 8G) while OVX mice showed low Sult1e1 expression that was unaffected by POP exposure. Lastly, the hepatic expression of Tnfa increased in POP-exposed sham mice while OVX mice showed greater variability but higher hepatic Tnfa transcript levels (Figure 8H). Collectively, these data demonstrated no POP-mediated effects on glucose intolerance and liver injury in OVX mice as compared to sham-operated mice.
Figure 8. Effects of POP exposure in an OVX model.

A) A glucose tolerance test was performed at 10 days post exposure in sham-operated and ovariectomized (OVX) mice with and with a one-time POP mixture administration. Glucose levels at each 30-minute timepoint were plotted and subgroup comparisons at individual timepoints performed. **p<0.05 vs. SHAM-CON and SHAM-EXPOSED, and *#p<0.05 vs. OVX-CON, SHAM-CON, SHAM-EXPOSED. B) Liver sections from sham-operated and OVX mice were stained with Hematoxylin & Eosin (H&E, 10x) to assess presence of lipid droplets (denoted by blue arrows). C) Whole livers were extracted at euthanasia and the liver to BW ratio (%) was calculated. D) Plasma triglyceride levels were measured using the Piccolo Chemistry Analyzer. Hepatic mRNA levels of E) Cyp1a1, F) Cyp2b10, G) Sult1e1, and H) Tnfa were measured using RT-PCR. Values are mean ± SD, and asterisk(s) denote significant subgroup comparisons. Values for p <0.05 are in bold.
DISCUSSION
MASLD affects approximately 30% of the American adult population and its prevalence increased over the last decade (Bellentani, 2017; Le et al., 2017; Ruhl and Everhart, 2015; Younossi et al., 2016). MASLD is more often seen in adults with obesity, diabetes, and hyperlipidemia (Farrell and Larter, 2006), emphasizing the close association between these metabolic disorders. The prevalence of related comorbidities such as the metabolic syndrome also increased by over 35% in the last decade, distinctly in middle-aged US adults (Ford, 2005; Hirode and Wong, 2020; Moore et al., 2017). Lifestyle and genetic factors cannot sufficiently explain the rise in these liver and metabolic disorders particularly in younger people. Therefore, investigating environmental factors such as exposures to toxicants and pollutants, and their interactions with nutritional factors is warranted. Our research group has demonstrated the occurrence of TASLD and its significance in liver health (Beier et al., 2025). Nonetheless, there is limited knowledge of the impact of toxicant exposures on women’s metabolic health and liver disease. Our acute studies in a mouse model of TASLD showed clear sex-dependent physiological associations with chemical exposures, with female mice exhibiting greater susceptibility to steatosis and males more prone to oxidative stress (Bolatimi et al., 2024; Luo et al., 2023; Wahlang et al., 2019b). We postulate that POPs behave both as EDCs and MDCs and reshape hepatic metabolic and functional pathways, in part, through chemical-mediated xenobiotic receptor interactions that cooperate with sex hormones and their receptors. Significantly, the current study examined how POPs acting as EDCs/MDCs interact with a hypercaloric diet at sub-chronic exposures to induce sex-specific liver and metabolic dysfunction.
Key findings suggested that females on overnutrition were more susceptible to development of steatosis and associated dyslipidemia vs. males when exposed to the POP mixture. Indeed, POP-exposed, WD-fed female mice exhibited higher liver triglycerides and cholesterol, and some early signs of inflammation, compared to their unexposed counterparts. POP-exposed male mice appeared to be at risk to other facets of liver injury, namely, oxidative stress and glucose resistance. MASLD development and its severe outcomes including hepatocellular carcinoma development are reportedly more prevalent in male patients, in part due to the pro-fibrotic and carcinogenic-promoting effects of androgens and the protective role of estrogens (Grossmann et al., 2019; Wahlang, 2023). However, the current observations suggest that TASLD development in mice may deviate from current disease paradigms with regards to sex considerations with females being more susceptible. While WD exacerbated some of the liver and metabolic phenotypic changes caused by POPs, the CD groups also exhibited transcriptional modifications with exposure, particularly for fundamental genes involved in energy metabolism and liver function. Indeed, POP-exposed females showed decreased hepatic expression of Apob, crucial for lipoprotein synthesis in the liver, and essential transcription factors in maintenance of hepatocyte physiology, including HNFs. In contrast, POP-exposed males showed altered expression of lipid metabolism genes (Scd1, Fabp1). Thus, the transcriptional reprogramming induced by the POP mixture was sex-specific.
Mechanism-wise, the POP mixture activated the AHR and CAR in both sexes, while PXR activation appeared to be male-specific, depending on the diet. The AHR belongs to the PAS domain transcription factor family and in addition to xenobiotics, AHR is also activated by endogenous tryptophan metabolites (Bock, 2017). Carcinogenesis studies have shown that robust AHR activation is required to cause cancer (Leclerc et al., 2021; National Toxicology, 2006b). The role of sustained AHR activation with low-dose POP exposures in MASLD is less characterized, although some studies have indicated its role in steatosis and metabolic disruption (Lee et al., 2010). In contrast to AHR, CAR and PXR are nuclear receptors. Similar to the AHR, CAR and PXR are also involved in maintenance of energy homeostasis, in addition to xenobiotic detoxification. Receptor-receptor interactions between AHR and ER have been reported in vitro (Tarnow et al., 2019). Activated AHR can inhibit ERα and downstream estrogenic effects via multiple mechanisms including enhanced ERα proteasomal degradation, while ERα positively regulates AHR signaling. CAR can also inhibit ERα-mediated signaling through coactivator sequestration (Min et al., 2002) or upregulated expression of Sult1e1 which inactivates estrogen (Yi et al., 2020). In the current study, WD upregulated Sult1e1 expression. Surprisingly, only POP-exposed females, but not males, in the CD-fed group, showed upregulated Sult1e1 expression. Notably, this group also demonstrated more robust CAR activation, evident from Cyp2b10 induction and computational analysis of the altered liver proteome. ERα and estrogen play beneficial roles in metabolic health by potentiating insulin secretion, attenuating hepatic steatosis, and regulating adipocyte differentiation (Meda et al., 2020; Mimoto et al., 2017; Palmisano et al., 2017). Estrogens also combat hepatic oxidative damage/ROS production in diet-induced obesity (Besse-Patin et al., 2017; Galmes-Pascual et al., 2020). Despite our inability to measure estrogen levels in the current study, it is appropriate to note that the POP mixture resulted in increased circulating testosterone levels in males while disrupting estrus cycle in females. Therefore, we postulate that the sex-specific mechanisms in the current study could be primary AHR and CAR activation leading to anti-estrogenic and pro-androgenic patterns, with subsequent loss of protective estrogenic effects against steatosis and inflammation in females. Findings from the OVX study, in part, substantiated this potential mechanism as the 2-week POP exposure administered as a one-time bolus dose induced hepatomegaly, hepatic inflammation and glucose intolerance in sham-operated but not OVX mice. It is plausible that the lack of exacerbation in the OVX model could be due to the proposed hepatotoxicity mechanism not being in effect. However, no notable effects on POP-mediated steatosis was observed in the 2-week OVX study and this could be due to the shorter duration of the study.
Other potential sex-specific mechanisms may involve differential tissue distribution and bioaccumulation of POPs. Both dietary composition and biological sex likely modulate the metabolic processing of chlordane and PCB 126, as well as the tissue-specific distribution of their bioaccumulated metabolites. Our gene expression assays clearly showed that WD interfered with the hepatic induction of xenobiotic receptor targets, Moreover, sex-dependent differences in the basal expression and activity of several drug-metabolizing enzymes have been documented (Huang et al., 2023; Uno et al., 2017), including in the present study. Biological sex also influences body composition patterns, particularly adipose tissue distribution (Lee et al., 2025), which is further modulated by WD feeding. Thus, given the lipophilic nature of these POPs and their propensity to bioaccumulate, the observed toxicities may, in part, reflect differences in the effective concentrations of these compounds within target organs or tissues.
To our knowledge this is the first study that utilizes a POP mixture of CAR and AHR activators, and WD, to examine hepatic TASLD endpoints and underlying sex differences. Hypercaloric diets represent a lifestyle factor given the prevalence of obesity in people diagnosed with MASLD, diabetes, and the metabolic syndrome (Vargas et al., 2024). This diet-induced obesity model is also designed to serve the “two-hit” or “multi-hit” hypothesis where exposure to POPs acts as a “first hit” leading to a “compromised liver”, and other lifestyle factors such as over-nutritional stress act as the “second-hit” that subsequently transforms a compromised liver state to liver injury (Wahlang et al., 2019a). Employing environmentally relevant doses of the POP components also renders this study applicable to current human exposure paradigms. The findings from this study also align with prior reports on PCBs and OCPs and the effects of the individual mixture components thereof. Specifically, females exhibited pronounced hepatic lipid dysregulation, whereas males displayed other toxicological manifestations, including oxidative stress, insulin resistance, and obesogenic effects (Wahlang, 2023). The current observations also carry broader implications for women’s liver and metabolic health. Notably, postmenopausal women are at an elevated risk of developing hepatic steatosis and MASLD (Lonardo et al., 2019), conditions that frequently emerge during or after menopause. The study findings suggest that exposures to EDCs/MDCs such as POPs may exacerbate these preexisting vulnerabilities and potentially worsen disease outcomes in older women. Furthermore, the data raise the possibility that such chemical exposures could shift the current paradigm by increasing susceptibility to metabolic disorders, including steatosis, even in premenopausal women.
Nonetheless, the current study is not without limitations. Firstly, POP tissue and circulatory levels were not measured in the current study, and this limited our understanding of the sex-specific mechanisms related to POP distribution patterns. Secondly, modulation of bile acids and changes in the lipidome landscape with POP exposure were not accounted for. Further, the study focused solely on a mouse exposure model and pivotal species differences exist between mouse and human AHR ligand binding pocket (Flaveny and Perdew, 2009), as a consequence of evolutionary adaptation to endogenous ligands. While human AHR activation by endogenous ligands is shown to be protective against inflammation and gut barrier dysfunction (Faber et al., 2022), activation by persistent organic toxicants is speculated as harmful. To address these limitations, future studies will include POP measurements, incorporation of humanized AHR mice to achieve human relevance pertinent to receptor mechanisms, bile acid measurements and liver-gut crosstalk analysis. Translating the current findings to exposed human populations will also be important. Since we observed that WD impacted AHR and CAR target gene expression, addressing how hypercaloric diets interact with POPs to modulate P450s in TASLD warrants further investigation. Incorporating exposure and dietary models that reflect real-world conditions, including prenatal or early-life toxicant exposures followed by hypercaloric diets during development and in adulthood, are also imperative towards achieving meaningful translational insight.
In conclusion, the current study focused on a subset of liver disease namely TASLD, a liver and metabolic pathology whose mechanisms are still poorly understood in female models and women populations. The findings demonstrated that WD-fed female mice exposed to POPs developed steatosis and dyslipidemia, while their male counterparts displayed signs of glucose intolerance and liver oxidative stress. Key mechanisms for these sex-specific effects included xenobiotic receptor activation and potential AHR- and CAR- interactions with sex hormone receptors that, in part, drove the sex-specific phenotypic changes. Moreover, both chemical-sex and chemical-diet interactions appeared decisive in driving disease phenotype. Studies using OVX models with estradiol supplementation will further validate estrogen-related mechanisms and provide insights on potential sex-specific interventions and therapy in TASLD.
Supplementary Material
Male and female mice were fed either a low-fat or western diet and exposed to a mixture of POPs
Western diet-fed females were more susceptible to steatosis when exposed to the POP mixture
In contrast, male mice exposed to the POP mixture exhibited signs of glucose intolerance and oxidative stress
POPs interact with various liver xenobiotic receptors and sex hormone receptors to induce their toxic effects
ACKNOWLEDGEMENTS
The authors acknowledge Jianzhu Luo for assistance with the animal studies, Daniel W. Wilkey for assistance with the proteomic experiments, and the Comparative Medical Research Unit (CMRU) staff at the University of Louisville for assistance with the survival surgeries.
FINANCIAL SUPPORT AND SPONSORSHIP
This research was supported, in part, by the National Institute of Environmental Health Sciences (K01ES033289, R25ES036039, P30ES030283); the National Institute of General Medical Sciences (P20GM113226), the Department of Defense Toxic Exposure Research Program (HT94252310949), the Jewish Heritage Fund Research Recruitment Grant Program at the University of Louisville, and the UofL Office of Research and Innovation.
ABBREVIATIONS
- Acaca
Acetyl-Coenzyme A carboxylase alpha
- AHR
arylhydrocarbon receptor
- Alb
Albumin
- Ar/AR
Androgen receptor
- Apob
Apolipoprotein B
- AUC
Area under the curve
- CD
Control diet
- Cd36
Cluster of differentiation
- Cpt1a
Carnitine palmitoyltransferase 1a, liver
- Cyp1a1
Cytochrome P450, family 1, subfamily a, polypeptide 1
- Cyp1a2
Cytochrome P450, family 1, subfamily a, polypeptide 2
- Cyp1b10
Cytochrome P450, family 2, subfamily b, polypeptide 10
- Cyp3a11
Cytochrome P450, family 3, subfamily a, polypeptide 11
- DE
Differentially expressed
- EDCs
Endocrine disrupting chemicals
- Egfr
Epidermal growth factor receptor
- ERα
Estrogen receptor alpha
- Esr1
Estrogen receptor alpha
- Sult1e1
Sulfotransferase family 1E, member 1
- Fabp1
Fatty acid binding protein
- Fasn/FAS
Fatty acid synthase
- FMO3
Flavin-containing monooxygenase 3
- Foxa1/Hnf3a
Forkhead box A1
- Gapdh
Glyceraldehyde-3-phosphate dehydrogenase
- Gck
Glucokinase
- GSH
Glutathione levels
- GSSG
Glutathione disulfide
- HDL
High density lipoproteins
- Hnf4a
Hepatocyte nuclear factor 4, alpha
- IACUC
Institutional Animal Care and Use Committee
- Il6
Interleukin 6
- IPF
Interaction by Protein Function
- MASLD
Metabolic dysfunction-associated steatotic liver disease
- MDCs
Metabolism disrupting chemicals
- OCPs
Organochlorine pesticides
- OVX
Ovariectomy
- PCBs
Polychlorinated biphenyls
- Pnpla2
Patatin-like phospholipase domain containing 2
- Ppara
Peroxisome proliferator activated receptor alpha
- Pck1
Phosphoenolpyruvate carboxykinase 1
- POPs
Persistent organic pollutants
- Serpine1/PaI-1
Plasminogen activator inhibitor 1
- Scd1
Stearoyl-Coenzyme A desaturase 1
- TASH
toxicant-associated steatohepatitis
- TASLD
Toxicant-associated steatotic liver disease
- Timp1
Tissue inhibitor of metalloproteinase 1
- Tnfa
Tumor necrosis factor
- WD
Western diet
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declaration of interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
REFERENCES
- National Report on Human Exposure to Environmental Chemicals. Biomonitoring Data Tables for Environmental Chemicals. Centers for Disease Control and Prevention (CDC). U.S. Department of Health and Human Services, Public Health Service; https://www.cdc.gov/exposurereport/index.html. [Google Scholar]
- 2018. Fourth National Report on Human Exposure to Environmental Chemicals. Updated Tables, Volume Two. Centers for Disease Control and Prevention (CDC). U.S. Department of Health and Human Services, Public Health Service. [Google Scholar]
- Batt AL, Wathen JB, Lazorchak JM, Olsen AR, Kincaid TM, 2017. Statistical Survey of Persistent Organic Pollutants: Risk Estimations to Humans and Wildlife through Consumption of Fish from U.S. Rivers. Environ Sci Technol 51, 3021–3031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beier JI, Luo J, Vanderpuye CM, Brizendine P, Muddasani P, Bolatimi O, Heinig SA, Ekuban FA, Siddiqui H, Ekuban A, Gripshover TC, Wahlang B, Watson WH, Cave MC, 2025. Environmental Pollutants, Occupational Exposures, and Liver Disease. Semin Liver Dis 45, 148–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bellentani S, 2017. The epidemiology of non-alcoholic fatty liver disease. Liver Int 37 Suppl 1, 81–84. [DOI] [PubMed] [Google Scholar]
- Besse-Patin A, Leveille M, Oropeza D, Nguyen BN, Prat A, Estall JL, 2017. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease. Gastroenterology 152, 243–256. [DOI] [PubMed] [Google Scholar]
- Bock KW, 2017. Human and rodent aryl hydrocarbon receptor (AHR): from mediator of dioxin toxicity to physiologic AHR functions and therapeutic options. Biol Chem 398, 455–464. [DOI] [PubMed] [Google Scholar]
- Bolatimi OE, Hua Y, Ekuban FA, Gripshover TC, Ekuban A, Luulay B, Watson WH, Hardesty JE, Wahlang B, 2024. Low dose exposure to dioxins alters hepatic energy metabolism and steatotic liver disease development in a sex-specific manner. Environ Int 194, 109152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cano R, Perez JL, Davila LA, Ortega A, Gomez Y, Valero-Cedeno NJ, Parra H, Manzano A, Veliz Castro TI, Albornoz MPD, Cano G, Rojas-Quintero J, Chacin M, Bermudez V, 2021. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Int J Mol Sci 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cave M, Falkner KC, Ray M, Joshi-Barve S, Brock G, Khan R, Bon Homme M, McClain CJ, 2010. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology 51, 474–481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Faber SC, Lahoti TS, Taylor ER, Lewis L, Sapiro JM, Toledo Sales V, Dragan YP, Jeffy BD, 2022. Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications. Cells 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farrell GC, Larter CZ, 2006. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99–S112. [DOI] [PubMed] [Google Scholar]
- Flaveny CA, Perdew GH, 2009. Transgenic Humanized AHR Mouse Reveals Differences between Human and Mouse AHR Ligand Selectivity. Mol Cell Pharmacol 1, 119–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ford ES, 2005. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28, 2745–2749. [DOI] [PubMed] [Google Scholar]
- Galmes-Pascual BM, Martinez-Cignoni MR, Moran-Costoya A, Bauza-Thorbrugge M, Sbert-Roig M, Valle A, Proenza AM, Llado I, Gianotti M, 2020. 17beta-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. Free Radic Biol Med 150, 148–160. [DOI] [PubMed] [Google Scholar]
- Grossmann M, Wierman ME, Angus P, Handelsman DJ, 2019. Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. Endocr Rev 40, 417–446. [DOI] [PubMed] [Google Scholar]
- Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, Nadal A, Palanza P, Panzica G, Sargis R, Vandenberg LN, Vom Saal F, 2017. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 68, 3–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirode G, Wong RJ, 2020. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011–2016. JAMA 323, 2526–2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holloway MG, Miles GD, Dombkowski AA, Waxman DJ, 2008. Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver. Mol Endocrinol 22, 1274–1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang Y, Shan Y, Zhang W, Lee AM, Li F, Stranger BE, Huang RS, 2023. Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes. Nat Commun 14, 175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, Nguyen MH, 2017. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One 12, e0173499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leclerc D, Staats Pires AC, Guillemin GJ, Gilot D, 2021. Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies. Curr Opin Immunol 70, 15–26. [DOI] [PubMed] [Google Scholar]
- Lee JH, Wada T, Febbraio M, He J, Matsubara T, Lee MJ, Gonzalez FJ, Xie W, 2010. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology 139, 653–663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee YG, Kang YR, Chang Y, Kim J, Sung MK, 2025. Sex Disparities in Obesity: A Comprehensive Review of Hormonal and Genetic Influences on Obesity-Related Phenotypes. Obes Rev, e70026. [DOI] [PubMed] [Google Scholar]
- Lee YM, Jacobs DR Jr., Lee DH, 2018. Persistent Organic Pollutants and Type 2 Diabetes: A Critical Review of Review Articles. Front Endocrinol (Lausanne) 9, 712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A, 2019. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology 70, 1457–1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luo J, Watson WH, Gripshover TC, Qaissi Z, Wahlang B, 2023. Sex-specific effects of acute chlordane exposure in the context of steatotic liver disease, energy metabolism and endocrine disruption. Food Chem Toxicol 180, 114024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meda C, Barone M, Mitro N, Lolli F, Pedretti S, Caruso D, Maggi A, Della Torre S, 2020. Hepatic ERalpha accounts for sex differences in the ability to cope with an excess of dietary lipids. Mol Metab 32, 97–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mimoto MS, Nadal A, Sargis RM, 2017. Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals. Curr Environ Health Rep 4, 208–222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Min G, Kim H, Bae Y, Petz L, Kemper JK, 2002. Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem 277, 34626–34633. [DOI] [PubMed] [Google Scholar]
- Moore JX, Chaudhary N, Akinyemiju T, 2017. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis 14, E24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- National Toxicology P, 2006a. Toxicology and carcinogenesis studies of a binary mixture of 3,3’,4,4’,5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2’,4,4’,5,5’-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies). Natl Toxicol Program Tech Rep Ser, 1–258. [PubMed] [Google Scholar]
- National Toxicology, P., 2006b. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3’,4,4’,5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies). Natl Toxicol Program Tech Rep Ser, 1–180. [PubMed] [Google Scholar]
- Palmisano BT, Zhu L, Stafford JM, 2017. Role of Estrogens in the Regulation of Liver Lipid Metabolism. Adv Exp Med Biol 1043, 227–256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pantier LK, Li J, Christian CA, 2019. Estrous Cycle Monitoring in Mice with Rapid Data Visualization and Analysis. Bio Protoc 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez-Montes L, Ovchinnikova S, Yuan X, Studer T, Sarropoulos I, Anders S, Kaessmann H, Cardoso-Moreira M, 2023. Sex-biased gene expression across mammalian organ development and evolution. Science 382, eadf1046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruhl CE, Everhart JE, 2015. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 41, 65–76. [DOI] [PubMed] [Google Scholar]
- Shannon M, Xie Y, Verhaegen S, Wilson J, Berntsen HF, Zimmer KE, Ropstad E, Green BD, Connolly L, 2019. A Human Relevant Defined Mixture of Persistent Organic Pollutants (POPs) Affects In Vitro Secretion of Glucagon-Like Peptide 1 (GLP-1), but Does Not Affect Translocation of Its Receptor. Toxicol Sci 172, 359–367. [DOI] [PubMed] [Google Scholar]
- Shi H, Jan J, Hardesty JE, Falkner KC, Prough RA, Balamurugan AN, Mokshagundam SP, Chari ST, Cave MC, 2019. Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes. Toxicol Appl Pharmacol 363, 22–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tarnow P, Tralau T, Luch A, 2019. Chemical activation of estrogen and aryl hydrocarbon receptor signaling pathways and their interaction in toxicology and metabolism. Expert Opin Drug Metab Toxicol 15, 219–229. [DOI] [PubMed] [Google Scholar]
- Uno Y, Takata R, Kito G, Yamazaki H, Nakagawa K, Nakamura Y, Kamataki T, Katagiri T, 2017. Sex- and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes. Drug Metab Pharmacokinet 32, 100–107. [DOI] [PubMed] [Google Scholar]
- Vargas M, Cardoso Toniasso SC, Riedel PG, Baldin CP, Dos Reis FL, Pereira RM, Brum MCB, Joveleviths D, Alvares-da-Silva MR, 2024. Metabolic disease and the liver: A review. World J Hepatol 16, 33–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahlang B, 2018. Exposure to persistent organic pollutants: impact on women’s health. Rev Environ Health 33, 331–348. [DOI] [PubMed] [Google Scholar]
- Wahlang B, 2023. RISING STARS: Sex differences in toxicant-associated fatty liver disease. J Endocrinol 258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, Bhatnagar A, McClain CJ, Cave M, 2013. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem 24, 1587–1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahlang B, Jin J, Beier JI, Hardesty JE, Daly EF, Schnegelberger RD, Falkner KC, Prough RA, Kirpich IA, Cave MC, 2019a. Mechanisms of Environmental Contributions to Fatty Liver Disease. Curr Environ Health Rep 6, 80–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahlang B, Jin J, Hardesty JE, Head KZ, Shi H, Falkner KC, Prough RA, Klinge CM, Cave MC, 2019b. Identifying sex differences arising from polychlorinated biphenyl exposures in toxicant-associated liver disease. Food Chem Toxicol 129, 64–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang D, Wang X, Zhang P, Wang Y, Zhang R, Yan J, Zhou Z, Zhu W, 2017. The fate of technical-grade chlordane in mice fed a high-fat diet and its roles as a candidate obesogen. Environ Pollut 222, 532–542. [DOI] [PubMed] [Google Scholar]
- Waxman DJ, Holloway MG, 2009. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76, 215–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu P, Foley C, Heiger-Bernays W, Chen C, 2024. Chemical mixtures of mercury, PCBs, PFAS, and pesticides in freshwater fish in the US and the risks they pose for fish consumption. Environ Res 266, 120381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yi M, Fashe M, Arakawa S, Moore R, Sueyoshi T, Negishi M, 2020. Nuclear receptor CAR-ERalpha signaling regulates the estrogen sulfotransferase gene in the liver. Sci Rep 10, 5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M, 2016. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84. [DOI] [PubMed] [Google Scholar]
- Yu G, Lu R, Yang J, Rahman ML, Li LJ, Wang DD, Sun Q, Pang WW, Guivarch C, Birukov A, Grewal J, Chen Z, Zhang C, 2024. Healthy dietary patterns are associated with exposure to environmental chemicals in a pregnancy cohort. Nat Food 5, 563–568. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
